000865194 001__ 865194
000865194 005__ 20210130002937.0
000865194 0247_ $$2doi$$a10.1093/neuonc/noz173
000865194 0247_ $$2ISSN$$a1522-8517
000865194 0247_ $$2ISSN$$a1523-5866
000865194 0247_ $$2altmetric$$aaltmetric:66465519
000865194 0247_ $$2pmid$$apmid:31504819
000865194 0247_ $$2WOS$$aWOS:000509393300018
000865194 037__ $$aFZJ-2019-04730
000865194 082__ $$a610
000865194 1001_ $$0P:(DE-Juel1)143792$$aGalldiks, Norbert$$b0$$eCorresponding author$$ufzj
000865194 245__ $$aComment on “Hypometabolic gliomas on FET-PET - Is there an inverted U-curve for survival?”, Kamson 2019, Neuro-Oncology
000865194 260__ $$aOxford$$bOxford Univ. Press$$c2019
000865194 3367_ $$2DRIVER$$aarticle
000865194 3367_ $$2DataCite$$aOutput Types/Journal article
000865194 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1576649499_5126
000865194 3367_ $$2BibTeX$$aARTICLE
000865194 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000865194 3367_ $$00$$2EndNote$$aJournal Article
000865194 520__ $$aWith great interest we read the editorial by Kamson entitled “Hypometabolic Gliomas on FET-PET—Is There an Inverted U-Curve for Survival?” in Neuro-Oncology1 referring to our publication regarding the clinical relevance of photopenic defects on O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET in glioma patients.2 In that paper, we identified within 100 patients with FET-PET–negative gliomas a subgroup of patients who even exhibit photopenic defects and had, moreover, an unfavorable outcome compared with gliomas with indifferent FET uptake (isometabolic gliomas). From our point of view, the frequency of photopenic defects is even lower than 10% (ie, ~5%). In his editorial, the author raised valuable new thoughts and ideas that are worth discussing.
000865194 536__ $$0G:(DE-HGF)POF3-572$$a572 - (Dys-)function and Plasticity (POF3-572)$$cPOF3-572$$fPOF III$$x0
000865194 588__ $$aDataset connected to CrossRef
000865194 7001_ $$0P:(DE-Juel1)171957$$aVerger, Antoine$$b1
000865194 7001_ $$0P:(DE-HGF)0$$aZaragori, Timothée$$b2
000865194 7001_ $$0P:(DE-HGF)0$$aUnterrainer, Marcus$$b3
000865194 7001_ $$0P:(DE-HGF)0$$aSuchorska, Bogdana$$b4
000865194 7001_ $$0P:(DE-HGF)0$$aLohman, Philipp$$b5
000865194 7001_ $$0P:(DE-HGF)0$$aTonn, Jörg C$$b6
000865194 7001_ $$0P:(DE-Juel1)131777$$aLangen, Karl-Josef$$b7$$ufzj
000865194 7001_ $$0P:(DE-HGF)0$$aAlbert, Nathalie L$$b8
000865194 773__ $$0PERI:(DE-600)2094060-9$$a10.1093/neuonc/noz173$$gp. noz173$$n12$$p1612-1613$$tNeuro-Oncology$$v21$$x1523-5866$$y2019
000865194 8564_ $$uhttps://juser.fz-juelich.de/record/865194/files/noz173.pdf$$yRestricted
000865194 8564_ $$uhttps://juser.fz-juelich.de/record/865194/files/noz173.pdf?subformat=pdfa$$xpdfa$$yRestricted
000865194 909CO $$ooai:juser.fz-juelich.de:865194$$pVDB
000865194 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich$$b0$$kFZJ
000865194 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-HGF)0$$aForschungszentrum Jülich$$b5$$kFZJ
000865194 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a INM-4$$b5
000865194 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131777$$aForschungszentrum Jülich$$b7$$kFZJ
000865194 9131_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000865194 9141_ $$y2019
000865194 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000865194 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEURO-ONCOLOGY : 2017
000865194 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000865194 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000865194 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000865194 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000865194 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000865194 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000865194 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000865194 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000865194 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bNEURO-ONCOLOGY : 2017
000865194 920__ $$lyes
000865194 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000865194 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x1
000865194 980__ $$ajournal
000865194 980__ $$aVDB
000865194 980__ $$aI:(DE-Juel1)INM-3-20090406
000865194 980__ $$aI:(DE-Juel1)INM-4-20090406
000865194 980__ $$aUNRESTRICTED